Naturally Occurring Cutaneous Anthrax: Antibiotic Treatment and Outcome

dc.contributor.authorKayabas, U.
dc.contributor.authorKarahocagil, M. K.
dc.contributor.authorOzkurt, Z.
dc.contributor.authorMetan, G.
dc.contributor.authorParlak, E.
dc.contributor.authorBayindir, Y.
dc.contributor.authorDoganay, M.
dc.date.accessioned2026-08-12T17:14:49Z
dc.date.issued2012
dc.departmentFırat Üniversitesi
dc.description.abstractObjectives: Cutaneous anthrax (CA) is the most common clinical presentation in human anthrax, but the duration of antibiotic therapy in naturally occurring CA is controversial. The aim of this study was to compare the clinical outcomes of patients receiving antibiotic treatment for either 3-5 days (group 1) or 7-10 days (group 2) in uncomplicated CA. Methods: A total of 66 patients were enrolled; 29 (44%) in group 1 and 37 (56%) in group 2. Infections were classified as mild (n = 22, 33%) or severe (n = 44, 67%) CA. Results: There were no significant differences between the groups in symptom resolution time, fever clearance time, healing of lesions, development and healing of eschars, requirement for surgical intervention or the development of complications. Both edema resolution time and duration of hospital stay were longer in group 2. There were no therapeutic failures, relapses or deaths in either group. Steroid therapy was used in 32% of patients with severe CA, but a beneficial effect on resolution of edema was not demonstrated. Conclusions: These results suggest that short-course antibiotic therapy is as effective as standard-duration therapy in uncomplicated CA and that steroid therapy may not be effective. Copyright (C) 2012 S. Karger AG, Basel
dc.identifier.doi10.1159/000335593
dc.identifier.endpage43
dc.identifier.issn0009-3157
dc.identifier.issn1421-9794
dc.identifier.issue1
dc.identifier.orcid0000-0003-3930-774X
dc.identifier.orcid0000-0002-2676-4557
dc.identifier.orcid0000-0002-5323-0796
dc.identifier.orcid0000-0003-3922-4901
dc.identifier.orcid0000-0002-5171-7306
dc.identifier.pmid22343361
dc.identifier.scopus2-s2.0-84856878949
dc.identifier.scopusqualityQ2
dc.identifier.startpage34
dc.identifier.urihttps://doi.org/10.1159/000335593
dc.identifier.urihttps://hdl.handle.net/11508/51957
dc.identifier.volume58
dc.identifier.wosWOS:000301625200005
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofChemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAnthrax
dc.subjectAntimicrobial therapy
dc.subjectBacillus anthracis
dc.subjectBacterial infection
dc.subjectCutaneous anthrax
dc.subjectGram-positive bacteria
dc.titleNaturally Occurring Cutaneous Anthrax: Antibiotic Treatment and Outcome
dc.typeArticle

Dosyalar